Should physicians be encouraged to use generic names and to prescribe generic drugs?

While using the brand names seems like a trivial issue at the outset, using these names is inherently problematic. Cardiovascular drugs remain the most commonly prescribed drugs by the physicians. The junior doctors are likely to introject practices of their seniors and consequently to reciprocate f...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 117; no. 11; pp. 1851 - 1852
Main Authors Riaz, Haris, MD, Krasuski, Richard A., MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2016
Elsevier Limited
Subjects
Acute coronary syndromes
Brand names
Cardiovascular
Cost analysis
Drug Prescriptions - statistics & numerical data
Drugs, Generic - therapeutic use
Generic drugs
Humans
Mortality
Pharmaceutical industry
Physicians
Physicians - standards
Practice Patterns, Physicians
Prescription drugs
Statins
Surveys and Questionnaires
Online AccessGet full text

Cover

More Information
Summary:While using the brand names seems like a trivial issue at the outset, using these names is inherently problematic. Cardiovascular drugs remain the most commonly prescribed drugs by the physicians. The junior doctors are likely to introject practices of their seniors and consequently to reciprocate from the experiences learnt from their preceptors. Using the generic names may be one way to facilitate prescription of the generic drugs who have a better cost profile and similar efficacy than the more expensive branded drugs. In this editorial, we have outlined several arguments to suggest the importance of using the generic names in academic discussions and clinical documentation.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2016.03.023